An acceptable survival prognosis was demonstrated by ITGA2, which was highly expressed during in vitro PDAC cell proliferation, apoptosis, and migration and ITGA2 was potential prognostic biomarkers for PDAC associated with IPMN 42. The gene discussed is ITGA2; the disease is pancreatic intraductal papillary-mucinous neoplasm.